Australasian Dental Practice

Monday, 4 December, 2023

31 Oct 2014 | Australasian Dental Practice

news > Briefs > Page 50

SomnoMed Ltd makes inroads into US market

Company Reporting and Announcements

SomnoMed Ltd (ASX:SOM), the leaders in Continuous Open Airway Therapy (COAT) has received approval from the US Government to have its oral appliances reimbursed by the US Medicare insurance program.

The company also launched its SomnoDent Herbst Advanced Classic and Flex Oral appliances for the treatment of obstructive sleep apnoea in the US. SomnoMed reported that it sold 4,535 sleep apnoea devices in September 2014, a 25.2% increase over the same period last year. The company also noted that it is constructing a new manufacturing facility in Australia that will double its production capacity. Since its launch, it has sold over 200,000 of its patented SomnoDent sleep apnoea appliances. SomnoMed is a publicly traded company (ASX:SOM) founded in 2004 in Sydney, Australia. The North American office, located in Frisco, Texas was opened in 2006 thus introducing their leading device technology to patients in America.

Stream the latest dental videos...
Soap vs COVID-19: A 3D-visualisation gamifies the power of simple hygiene

Upcoming Events...

Dec 06 2023



Jan 08 2024
Feb 13 2024
Mar 12 2024
Mar 13 2024
Mar 21 2024

ADX24 Sydney


Apr 16 2024

Dentists Behaving 'Very' Badly


Apr 19 2024

IDEM Singapore 2024

Singapore, SINGAPORE

May 14 2024
May 24 2024
Mar 25 2025

IDS 2025

Cologne, GERMANY

May 08 2025